OTCMKTS:REMI Remedent (REMI) Stock Price, News & Analysis → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free REMI Stock Alerts $0.06 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$0.06▼$0.0650-Day Range$0.04▼$0.0852-Week Range$0.00▼$0.17VolumeN/AAverage Volume50 shsMarket Capitalization$1.10 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest Get Remedent alerts: Email Address Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. About Remedent Stock (OTCMKTS:REMI)Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. Further, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice that enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Additionally, it provides dental implant solutions and treatment concepts. The company sells its products through internal sales force and third party distributors. Remedent, Inc. was incorporated in 1986 and is headquartered in Ghent, Belgium.Read More REMI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart REMI Stock News HeadlinesApril 24, 2024 | seekingalpha.comREMYY Rémy Cointreau SAFebruary 15, 2024 | health.usnews.comPeterson RemyMay 4, 2024 | InvestorPlace (Ad)Elon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” June 2, 2023 | yahoo.comRemi Wolf Returns with New Single “Prescription,” Inspired by Phone Call with Boots Riley: StreamMarch 22, 2023 | mirror.co.ukLove Island star Remi Lambert claims he was assaulted by one of Jacques O'Neill's friendsJanuary 25, 2023 | uk.news.yahoo.comWhere is Remi Adeleke and who is Chris Oliver from SAS: Who Dares Wins?August 22, 2022 | finance.yahoo.comRemedent, Inc. (REMI)August 21, 2021 | barrons.comRemedent Inc.See More Headlines Receive REMI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Remedent and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/04/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Dental equipment & supplies Sub-IndustryN/A Current SymbolOTCMKTS:REMI CUSIPN/A CIK1078037 Webwww.remedent.com Phone(329) 241-5880Fax329-241-5899Employees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares20,000,000Free FloatN/AMarket Cap$1.10 million OptionableNot Optionable Beta-0.11 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Guy De Vreese (Age 69)Chairman & CEO Mr. Philippe Van Acker (Age 59)CFO, Chief Accounting Officer & Director Comp: $188.01kKey CompetitorsSmileDirectClubNASDAQ:SDCCQGreen Organic DutchmanOTCMKTS:TGODFSintx TechnologiesNASDAQ:SINTAcorda TherapeuticsNASDAQ:ACORQQHSLabOTCMKTS:USAQView All Competitors REMI Stock Analysis - Frequently Asked Questions How have REMI shares performed in 2024? Remedent's stock was trading at $0.0970 at the beginning of 2024. Since then, REMI stock has decreased by 43.3% and is now trading at $0.0550. View the best growth stocks for 2024 here. What other stocks do shareholders of Remedent own? Based on aggregate information from My MarketBeat watchlists, some companies that other Remedent investors own include CoStar Group (CSGP), Enterprise Products Partners (EPD), Kellanova (K), MKS Instruments (MKSI), M&T Bank (MTB), Old Line Bancshares (OLBK), RH (RH), AT&T (T), Taiwan Semiconductor Manufacturing (TSM) and How do I buy shares of Remedent? Shares of REMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:REMI) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCFW: 234x GainWeiss RatingsCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Remedent, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.